Clinical Trial Update: China HVT Safety, PK, PD [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update in China assessing safety, pharmacokinetics, and pharmacodynamics of HVT for osteoporosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• HVT

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED